Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1996-12-13
1999-03-09
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514177, 514168, 514171, A61K 3156
Patent
active
058801162
ABSTRACT:
The present invention provides a method for treating patients with Alzheimer's Disease which comprises administering a an effective amount of a celastrol formulation to the patients. One source of raw material for such a celastrol formulation is the root of the vine tripterygium wilfordii Hook F.
REFERENCES:
patent: 4328309 (1982-05-01), Chalmers et al.
patent: 4746674 (1988-05-01), Pierpaoli et al.
patent: 5192753 (1993-03-01), McGeer et al.
patent: 5500340 (1996-03-01), Lipsky et al.
Li X.-Y, Anti-Inflam. Components of Tript. Wilfordii Hook F. (1993) Int. J. Immunotherapy IX(3): 181-187.
McGeer et al., Anti-Inflammatory drugs & Alzheimer's Disease, (1990) Lancet 335:1037.
Evans et al., Prevalence of Alzhemier's (1989) JAMA 262(18): 2551-56.
Reisberg, ed., Alzheimer's Disease (1983) Free Press Div of MacMillan, New York City, pp. 141-148.
Sulkava et al., Prevalence of Severe Dementia in Finland (1985) Neurology 35:1025-29.
Itagaki et al., Presence of T-cytotoxic suppresor . . . in Alzheimer's (1988) Neurosci. Lett. 91: 259-64.
Rogers et al., Expression of Immune Antigens . . . Relationship to Alzheimer's (1988) Neurosci. Ag. 9:339-49.
McGeer et al., Immune System Response in Alzheimer's Disease (1989) Can. J. Neurolog. Sci. 16:516-27.
McGeer et al. Activation of complement in Alzheimer patients (1989) Neurosci. Lett. 107:341-46.
Tachibana et al., Xenon Contrast Brain Changes in Alzheimer (1984) J. Gerontol. 39(4):415-23.
Criares Theodore J.
Luther Barbara J.
Neurocal International
LandOfFree
Use of celastrol to treat alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of celastrol to treat alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of celastrol to treat alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1321324